Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for P3 Health Partners Inc. (PIII : NSDQ)

• Company Description    P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. Number of Employees: 320

• Price / Volume Information    Yesterday's Closing Price: $13.20 Daily Weekly Monthly 20 Day Moving Average: 3,838,714 shares Shares Outstanding: 7.21 (millions) Market Capitalization: $95.22 (millions) Beta: 0.48 52 Week High: $14.89 52 Week Low: $1.52 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 386.19% 362.44% 12 Week 494.59% 449.67% Year To Date 278.22% 265.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2370 Corporate Circle Suite 300 - Henderson,NV 89074 USA ph: 702-910-3950 fax: - investors@p3hp.org https://p3hp.org

• General Corporate Information    Officers Aric Coffman - Chief Executive Officer Mark Thierer - Chairman Leif Pedersen - Chief Financial Officer Gregory N. Kazarian - Director Lawrence B. Leisure - Director Peer Information P3 Health Partners Inc. (HLIS) P3 Health Partners Inc. (AZTA) P3 Health Partners Inc. (APYI) P3 Health Partners Inc. (RNVA) P3 Health Partners Inc. (HMSY) P3 Health Partners Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 744413204 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 7.21 Most Recent Split Date: 4.00 (0.02:1) Beta: 0.48 Market Capitalization: $95.22 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.06 EPS Growth vs. Year Ago Period: 84.24% vs. Previous Quarter: 95.70% Sales Growth vs. Year Ago Period: 3.53% vs. Previous Quarter: 0.41% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - -302.33 ROA 03/31/26 - -19.99 12/31/25 - -20.72 09/30/25 - -16.72 Current Ratio 03/31/26 - 0.33 12/31/25 - 0.24 09/30/25 - 0.32 Quick Ratio 03/31/26 - 0.33 12/31/25 - 0.24 09/30/25 - 0.32 Operating Margin 03/31/26 - -9.32 12/31/25 - -10.14 09/30/25 - -8.63 Net Margin 03/31/26 - -8.57 12/31/25 - -10.14 09/30/25 - -9.07 Pre-Tax Margin 03/31/26 - -19.42 12/31/25 - -22.00 09/30/25 - -19.27 Book Value 03/31/26 - -19.90 12/31/25 - -21.55 09/30/25 - -2.60 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©